Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$147M |
| 2 |
NVIDIA
NVDA
|
+$129M |
| 3 |
iShares Bitcoin Trust
IBIT
|
+$124M |
| 4 |
SPR
Spirit AeroSystems
SPR
|
+$109M |
| 5 |
INFN
Infinera Corporation Common Stock
INFN
|
+$98.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$97.9M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$93.9M |
| 3 |
UnitedHealth
UNH
|
+$68.8M |
| 4 |
Salesforce
CRM
|
+$57M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$56.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.46% |
| 2 | Financials | 3.89% |
| 3 | Industrials | 3.8% |
| 4 | Consumer Discretionary | 3.36% |
| 5 | Healthcare | 3.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Petrobras Class A
PBR.A
$108B
| $181K | ﹤0.01% |
+13,752
| New | +$186K |
|
|
ORC
2552
Orchid Island Capital
ORC
$1.34B
| $180K | ﹤0.01% |
+21,940
| New | +$181K |
|
2553
Biomea Fusion
BMEA
$120M
| $180K | ﹤0.01% |
+17,838
| New | +$116K |
|
2554
Codexis
CDXS
$185M
| $179K | ﹤0.01% |
58,093
-41,593
| -42% | -$129K |
|
2555
Acco Brands
ACCO
$392M
| $173K | ﹤0.01% |
31,667
-99,947
| -76% | -$505K |
|
2556
Lyell Immunopharma
LYEL
$370M
| $172K | ﹤0.01% |
6,216
| – | – |
|
2557
Sabre
SABR
$884M
| $171K | ﹤0.01% |
+46,688
| New | +$145K |
|
2558
PLAYSTUDIOS Inc
MYPS
$61.3M
| $170K | ﹤0.01% |
112,819
| – | – |
|
2559
Fate Therapeutics
FATE
$285M
| $169K | ﹤0.01% |
48,169
+2,879
| +6% | +$11.2K |
|
2560
SLR Investment Corp
SLRC
$691M
| $168K | ﹤0.01% |
11,168
-18,328
| -62% | -$285K |
|
2561
CALL
Bloomin' Brands
BLMN
$991M
| $165K | ﹤0.01% |
+10,000
| New | +$177K |
|
2562
Intuitive Machines
LUNR
$2.71B
| $160K | ﹤0.01% |
+19,844
| New | +$98.7K |
|
|
ETWO
2563
DELISTED
E2open Parent Holdings
ETWO
| $153K | ﹤0.01% |
+34,742
| New | +$152K |
|
2564
Purple Innovation
PRPL
$24.7M
| $149K | ﹤0.01% |
6,026
| – | – |
|
2565
PUT
Vale
VALE
$64.3B
| $145K | ﹤0.01% |
+12,400
| New | +$133K |
|
2566
SGHC Ltd
SGHC
$7.17B
| $141K | ﹤0.01% |
38,751
| – | – |
|
|
CDMO
2567
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $134K | ﹤0.01% |
11,803
-19,234
| -62% | -$193K |
|
2568
Pacific Biosciences
PACB
$395M
| $133K | ﹤0.01% |
+78,171
| New | +$128K |
|
2569
DMC Global
BOOM
$140M
| $132K | ﹤0.01% |
10,146
-34,621
| -77% | -$438K |
|
|
RDFN
2570
CALL
DELISTED
Redfin
RDFN
| $132K | ﹤0.01% |
+10,500
| New | +$96.5K |
|
2571
Zentalis Pharmaceuticals
ZNTL
$363M
| $131K | ﹤0.01% |
+35,709
| New | +$130K |
|
2572
Erasca
ERAS
$6.11B
| $131K | ﹤0.01% |
+47,830
| New | +$135K |
|
2573
CALL
Aehr Test Systems
AEHR
$3.16B
| $129K | ﹤0.01% |
+10,000
| New | +$145K |
|
|
RPC
2574
Ridgepost Capital
RPC
$980M
| $127K | ﹤0.01% |
+11,826
| New | +$116K |
|
2575
Wave Life Sciences
WVE
$1.01B
| $125K | ﹤0.01% |
+15,202
| New | +$90.9K |
|
Similar funds
Paul Tudor Jones's Q3 2024 Portfolio in Review
As of Q3 2024, Paul Tudor Jones held 3,231 positions worth $27.5B, up 41% from $19.5B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Paul Tudor Jones deployed $6.72B of net new capital in Q3 2024, opening 973 new positions and adding to 833 existing holdings. Its largest new stake was iShares Russell 2000 ETF: 686,581 shares worth $152M.
By sector, the portfolio is most concentrated in Technology at 6.5% of assets, down from 8.7% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Apple, an estimated $97.9M trimmed.
- Paul Tudor Jones's largest Q3 2024 buy was iShares Russell 2000 ETF: 686,581 shares worth $152M.
- Paul Tudor Jones added most to NVIDIA in Q3 2024, an estimated $129M increase.
- Paul Tudor Jones's biggest Q3 2024 reduction was Apple, cutting an estimated $97.9M.
- Paul Tudor Jones fully exited Bristol-Myers Squibb in Q3 2024, selling an estimated $93.9M.
- Paul Tudor Jones's ten largest holdings make up 47% of its $27.5B portfolio in Q3 2024.
- Paul Tudor Jones opened 973 new positions and closed 594 in Q3 2024.
- Paul Tudor Jones's portfolio value rose 41% quarter-over-quarter to $27.5B.
Based on Tudor Investment Corp's 13F filing for Q3 2024, filed 14 Nov 2024.